Common Non-Surgical Diseases of the Canine Spine
World Small Animal Veterinary Association World Congress Proceedings, 2008
Jacques Penderis, BVSc, MVM, PhD, CVR, DECVN, MRCVS
Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow
Glasgow, UK

Introduction

The disease of the canine spine can be classified based on whether the primary presenting complaint is spinal pain or neurological deficits.

Clinically important spinal cord diseases presenting with pain:

 Meningitis

 Discospondylitis

 Intervertebral disc disease*

 Lumbosacral syndrome*

 Bone tumour*

 Vertebral malformations (atlanto-axial subluxation)*

* May progress to develop neurological deficits

Clinically important spinal cord diseases presenting with neurological deficits:

 Intervertebral disc disease

 Fibrocartilaginous embolism

 Lumbosacral syndrome

 Trauma

 Neoplasia

 Vertebral malformations (atlanto-axial subluxation, hemivertebrae)

 Chronic degenerative radiculomyelopathy (CDRM or degenerative myelopathy) in the GSD

Meningitis

Causes of meningitis in dogs and cats include:

 Immune mediated form commonest: steroid responsive meningitis / arteritis (SRMA)

 (Bacterial: rapidly fatal)

 (Viral [distemper])

 (Protozoal [Toxoplasma / Neospora])

Breeds affected by SRMA:

 Large pure breeds (Pyrenean mountain dog, Newfoundland, pointer, Weimaraner, Vizsla)

 Beagles

Clinical Signs of SRMA

Typically a waxing and waning course, associated with bouts when the dog appears unwell, demonstrates pyrexia, marked cervical pain and inappetence.

Diagnosis

CSF tap is definitive, with evidence of elevated white cell counts, primarily consisting of large numbers of non-degenerate neutrophils. Haematology / biochemistry may support inflammation but are non-specific. Advanced imaging (besides MRI) is usually normal and myelography is contra-indicated.

Treatment

Prednisolone: tapering from an initial immunosuppressive dose for 2 to 4 weeks. Continue tapering the dose over 4 to 6 months. Some patients require longer treatment or different drugs. May be self limiting after 12-18 months.

Discospondylitis

Discospondylitis is a concurrent infection of the intervertebral disk and of the adjacent vertebral bodies (vertebral osteomyelitis). Discospondylitis is more common in middle-aged large/giant breed dogs. Males are more commonly affected than females (ratio of 2:1). The most common sites affected are mid-thoracic vertebrae; C6-C7 and L7-S1.

Aetiology

Discospondylitis is a septic condition, usually spread by haematogenous route. It can also be secondary to penetrating wounds, foreign bodies, etc. Commonly encountered infectious agents are coagulase-positive Staphylococci, Streptococcus species, Brucella canis and E. coli.

Clinical Presentation

Signs are often non-specific in the early stages. Spinal pain is usually present, while systemic signs (fever, weight loss) are reported in only 30% of cases. With progression, degeneration of the disc can lead to protrusion/extrusion.

Diagnosis

Leukocytosis is usually absent. CSF analysis is often normal. Blood and urine cultures are reported to be positive in 45-75% and 25-50% of cases, respectively. Brucella titres should be obtained in intact animals in endemic regions. Radiographic demonstration of discospondylitis is usually sufficient for diagnosis, but radiographic changes may not appear for up to 3 weeks. Magnetic resonance imaging is the diagnostic procedure of choice.

Treatment

Treatment of discospondylitis is prolonged (2 to 4 months) and relapses are not uncommon. Empirical treatment can be initiated after all samples (urine, blood, disc aspirate) have been taken for culture and sensitivity. Cage rest is important to minimize the risk of pathologic fracture. Analgesia should be provided.

Intervertebral Disc Disease

Intervertebral disc disease is an important cause of canine neurological disease, accounting for over 2% of all diseases diagnosed in the dog. Affected patients typically present with signs of pain or varying degrees of spinal cord dysfunction. Disc disease in the dog was first classified by Hansen as:

 Type I, where herniation of the nucleus pulposus occurs through the annular fibres of the disc into the spinal canal; and

 Type II, where annular protrusion into the spinal canal is caused by shifting of the nucleus pulposus material. Both Hansen type I and type II disc disease are always preceded by disc degeneration.

A third type of disc extrusion, traumatic disc extrusion, may also occur. This happens when trauma causes rupture of a disc that demonstrated no obvious preceding degenerative changes, resulting in spinal cord injury with no or minimal residual compression.

Fibrocartilaginous Embolism (FCE)

Aetiology

FCE is characterised by ischaemia of the spinal cord secondary to the acute occurrence of emboli, consisting of disc-derived fibrocartilage, within the arterial and, occasionally, venous blood supply of the spinal cord. FCE often occurs in association with vigorous exercise or mild trauma (60% in one study).

Breed Predisposition

FCE occurs in either sex of usually adult dogs, but may occur from as early as a few months of age. FCE occurs virtually exclusively in non-chondrodystrophoid breeds and particularly in active medium/large breeds. However, there appears to be a breed predisposition for the development of FCE in miniature Schnauzers. In non-giant breeds, 80% of cases occur between 3 and 6 years of age.

Clinical Presentation

The onset of FCE is typically peracute and may be associated with a brief episode of pain, but thereafter the disease is non-progressive and pain-free. It may occur in any region of the spinal cord, but appears to be more frequent in the cervical and the thoracolumbar regions, particularly the cervical and lumbar enlargements. The neurological deficits are usually asymmetrical.

Diagnosis

Diagnosis is based on the correct history and signalment with no evidence of spinal cord compression. MRI is the most useful imaging modality for making an ante mortem diagnosis of FCE and the primary imaging feature is asymmetrical hyperintensity within the spinal cord on T2-weighted images.

Treatment and Prognosis

Treatment is by nursing care and early instigation of physiotherapy is very beneficial. As there is no residual spinal cord compression there is no need for decompressive surgery or for strict cage rest, and physiotherapy can therefore be started as soon as the diagnosis is confirmed.

Lumbosacral Syndrome

Lumbosacral syndrome comprises diseases affecting the caudal lumbar (L4-L7) and sacral segments of the spinal cord, as well as the nerve roots supplied by these spinal cord segments forming the cauda equine. The nerves affected by lumbosacral syndrome may include the femoral, sciatic, obturator, pudendal, pelvic and coccygeal nerves and result in variable involvement of the pelvic limbs, tail, bladder, anal sphincter and perineum.

Clinical Signs

The primary clinical signs of lumbosacral syndrome (the presence or absence of the individual clinical signs will depend on the underlying lesion) can roughly be subdivided into 3 categories:

Neurological deficits pertaining to the pelvic limbs:

 Pelvic limb paresis or ataxia

 Decreased lumbosacral trunk reflexes in the pelvic limb

 Pelvic limb or hip region muscle atrophy

Neurological deficits pertaining to the sacral and coccygeal nerve roots:

 Decrease or loss of the anal reflex and dilation of the anal sphincter

 Decreased or absent perineal reflexes

 Urinary incontinence

 Faecal incontinence

 Hypoaesthesia or analgesia of the perineal region, pelvic limb or tail

 Tail paralysis

Pain-related clinical signs:

 Pain over the lumbosacral region

 Reduced activity, in particular reluctance to jump and climb stairs

 Nerve root signature (referred pain due to nerve root entrapment)

Causes

The causes of lumbosacral syndrome are varied and include (based on the DAMNIT classification):

 Degenerative: lumbosacral stenosis, intervertebral disc disease, spinal synovial cysts

 Developmental: spina bifida, sacrocaudal dysgenesis, dermoid sinus, myelodysplasia, transitional lumbar or sacral vertebrae, osteochondritis dissecans

 Angiopathic: aortic ischaemic myelopathy, fibrocartilaginous embolism, haemorrhage, ascending and descending syndrome

 Neoplastic: primary and secondary spinal cord tumours, nerve root tumours

 Inflammatory and Infectious: abscessation, discospondylitis, (granulomatous meningoencephalomyelitis), (mycotic diseases), (parasitic migration)

 Trauma: spinal trauma

Of these causes of lumbosacral syndrome, the most important is lumbosacral stenosis.

Lumbosacral Stenosis

Lumbosacral stenosis is due to stenosis of the vertebral canal at the level of the lumbosacral junction with consequent compression of the nerve roots. In some cases, the stenosis may be lateralised and only affect one intervertebral foramen. The most common cause of lumbosacral stenosis is a Hansen type-II intervertebral disc extrusion at the level of the lumbosacral junction, but other causes have been reported. The condition is most common in large breed dogs, often working dogs. The disease tends to occur in middle-aged dogs, with an increased incidence in male dogs (with a male to female ratio of 4:1). German shepherd dogs, boxers and Rottweilers are over-represented.

Affected dogs demonstrate one or more of the features of lumbosacral syndrome, with pain over the lumbosacral region (particularly on palpation and lumbosacral hyperextension) being one of the most consistent clinical signs.

Trauma

Spinal trauma is a common cause of spinal dysfunction and includes endogenous and exogenous causes. Exogenous causes are most often secondary to road traffic accident or fall from a height.

Vertebrae can be divided in three anatomical compartments:

 Ventral: ventral longitudinal ligament, ventral part of the annulus fibrosus and ventral vertebral body

 Middle: dorsal portion of the annulus fibrosus, dorsal longitudinal ligament and dorsal vertebral body

 Dorsal: pedicles, vertebral arches, articular facets, joint capsules, spinous process and interspinous ligament

Treatment

Assessment of instability: considered unstable if there is a lesion of two or more compartments. The aim of spinal trauma treatment is to: 1) prevent further mechanical damage to the spinal cord; and 2) treat/prevent secondary pathophysiological events. The choice of treatment (conservative or surgical) depends on severity of the lesion (especially number of vertebral compartments involved), owner's finance, surgeon expertise and preference.

Neoplasia

Neoplasia affecting the spinal cord is common in both dogs and cats and the exact clinical signs depend on the localisation of the lesion, with respect to the level of the spinal cord affected (e.g., cervical versus caudal lumbar). Neoplasia of the spine is classified both with respect to the physical localisation in relation to the meninges and spinal cord (into extradural, intradural but extramedullary and intramedullary).

Vertebral Malformations (Atlanto-Axial Subluxation, Hemivertebrae)

Atlanto-Axial Subluxation

Toy and small breeds such as the Chihuahua and Yorkshire terrier are at highest risk as a result of failure of development of the dens (aplasia or hypoplasia). Onset of clinical signs in dogs with the congenital form usually occurs in young animals, although the problem can develop at any age, especially following minor trauma. Clinical signs are those associated with cervical spinal cord compression: pain, ataxia and/or upper motor neuron paresis/paralysis.

Malformations of the Vertebral Body and Disc

Most of these malformations are incidental findings and do not cause any significant neurological deficits, however in some cases, the spinal canal can be severely reduced, causing compression of the spinal cord.

Malformations of the Vertebral Arch and Spinal Cord

Spina Bifida

Incomplete closure of the vertebral arch. It is most commonly reported in English bulldogs and can cause paraparesis and urinary and faecal incontinence.

Congenital Syringomyelia and Spinal Dysraphism (Myelodysplasia)

Malformations of the spinal cord have been described in Weimaraner and other breeds of dogs.

Sacro-coccygeal Dysgensis

Reported in the Manx cat as well as pugs and bulldogs. The clinical signs include paraparesis and urinary/faecal incontinence.

Chronic Degenerative Radiculomyelopathy (CDRM or Degenerative Myelopathy)

Chronic degenerative radiculomyelopathy (CDRM) is a degenerative neurological disorder resulting in progressive pelvic limb ataxia and paresis in older large breed dogs, particularly the German shepherd dog. The underlying pathogenesis is unclear, but is likely to have a genetic basis.

Clinical Signs

Affected dogs are generally over six years of age and the mean age of onset is around 9-years of age. Clinically, dogs present with a gradual progression of an initial insidious pelvic limb ataxia. The neurological abnormalities are bilateral and usually symmetrical (although mild asymmetry is not uncommon). The lesion is diffuse and there are therefore no focal localising signs, such as focal pain or cutaneous trunci reflex cut-off. Due to involvement of the dorsal roots, the patellar reflex is decreased or lost in about 25% of cases. The duration of clinical disease prior to euthanasia on humane grounds is around 6 to 18 months.

Diagnosis

There is currently no in vivo diagnostic test: definitive diagnosis requires neuropathological examination.

Treatment

A variety of treatment regimes have been proposed, but there is no reliable evidence to suggest that any of these treatments offer any benefit. Concurrent osteoarthritis will, however, exacerbate the abnormal pelvic limb gait, and treatment with NSAIDs may result in apparent temporary improvement.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Jacques Penderis, BVSc, MVM, PhD, CVR, DECVN, MRCVS
Institute of Comparative Medicine, Faculty of Veterinary Medicine
University of Glasgow
Glasgow, United Kingdom


MAIN : Neurology : Canine Spine
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27